In comparison with IL-2 monotherapy, RAPA + IL-2 combination failed to cure T1D due to the unexpected deleterious impact on pancreatic beta cell proliferation, glucose tolerance and metabolism in the NOD model, despite boosting Tregs. This evidence concerns the gene IL2 and type 1 diabetes mellitus.